---
title: "Popular pre-market trades in the US stock market: CPS Tech up 13.58% pre-market; Leifras down 13.26% pre-market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287739552.md"
description: "CPS Tech pre-market up 13.58%; Leifras pre-market down 13.26%; Soligenix pre-market up 104.68%; Founder pre-market up 81.91%; Nanoviricides pre-market up 45.70%"
datetime: "2026-05-27T08:32:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287739552.md)
  - [en](https://longbridge.com/en/news/287739552.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287739552.md)
generator: "portal-rs"
---

# Popular pre-market trades in the US stock market: CPS Tech up 13.58% pre-market; Leifras down 13.26% pre-market

**Pre-market Hot Trades in US Stocks**

CPS Tech, up 13.58% in pre-market trading, has no significant news recently. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Leifras, down 13.26% in pre-market trading, has no significant news recently; the trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no\_news

**Top Gainers in Pre-market US Stocks**

Soligenix, up 104.68% in pre-market trading. Based on recent key news:

1.  On May 26, Soligenix announced important data regarding thermal stability, immunogenicity, and efficacy against similar viruses. This progress paves the way for the rapid development of the vaccine. The company plans to leverage this information to accelerate the vaccine development process, significantly boosting the stock price. Source: PR Newswire The biopharmaceutical industry has been active recently.

Founder, up 81.91% in pre-market trading, has no significant news recently. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Nanoviricides, up 45.70% in pre-market trading. Based on recent key news:

1.  On May 26, NanoViricides Inc. released important content through ACCESS Newswire, leading to a significant increase in stock price. The company disclosed its latest R&D progress in the news, attracting investor attention and pushing the stock price up 45.70% in pre-market trading. The biotechnology industry has been performing strongly recently, with clear capital inflows

### Related Stocks

- [CPSH.US](https://longbridge.com/en/quote/CPSH.US.md)
- [LFS.US](https://longbridge.com/en/quote/LFS.US.md)
- [SNGX.US](https://longbridge.com/en/quote/SNGX.US.md)
- [FGL.US](https://longbridge.com/en/quote/FGL.US.md)
- [NNVC.US](https://longbridge.com/en/quote/NNVC.US.md)

## Related News & Research

- [CPS Technologies releases transcript of Q2 2026 earnings call](https://longbridge.com/en/news/296806465.md)
- [Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study](https://longbridge.com/en/news/297453992.md)
- [Is Coca-Cola’s Q2 Beat And Upgraded Outlook Altering The Investment Case For KO?](https://longbridge.com/en/news/297406357.md)
- [Merck & Co., Inc. $MRK Shares Bought by Benjamin Edwards Inc.](https://longbridge.com/en/news/297416761.md)
- [ROI-Europe's autumn reckoning — bonds, budgets, billionaires: Mike Dolan](https://longbridge.com/en/news/296992818.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**